Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | POLYMER SCIENCE//CHEMISTRY, PHYSICAL//MATERIALS SCIENCE, MULTIDISCIPLINARY | 1554940 |
88 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//CHITOSAN | 80849 |
411 | 2 | SOLID LIPID NANOPARTICLES//POLYMERIC MICELLES//NANOSTRUCTURED LIPID CARRIERS | 17026 |
18346 | 1 | CANCER NANOTECHNOLOGY//SHENZHEN GENE ANTIBODY THER Y//NANOSCI NANOENGN INITIAT NUSNNI | 580 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CANCER NANOTECHNOLOGY | authKW | 1379646 | 8% | 54% | 47 |
2 | SHENZHEN GENE ANTIBODY THER Y | address | 1018978 | 7% | 49% | 38 |
3 | NANOSCI NANOENGN INITIAT NUSNNI | address | 531558 | 3% | 65% | 15 |
4 | CHEMOTHERAPEUTIC ENGINEERING | authKW | 521641 | 2% | 80% | 12 |
5 | TPGS | authKW | 511907 | 5% | 30% | 31 |
6 | VITAMIN E TPGS | authKW | 357630 | 4% | 31% | 21 |
7 | MOLECULAR BIOMATERIALS | authKW | 316145 | 1% | 73% | 8 |
8 | PHARMACEUTICAL NANOTECHNOLOGY | authKW | 279440 | 2% | 43% | 12 |
9 | PLGA TPGS | authKW | 194062 | 1% | 71% | 5 |
10 | D ALPHA TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATE | authKW | 177828 | 1% | 55% | 6 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Materials Science, Biomaterials | 9528 | 22% | 0% | 125 |
2 | Pharmacology & Pharmacy | 3179 | 43% | 0% | 252 |
3 | Nanoscience & Nanotechnology | 1782 | 20% | 0% | 114 |
4 | Engineering, Biomedical | 1241 | 12% | 0% | 70 |
5 | Chemistry, Multidisciplinary | 289 | 17% | 0% | 98 |
6 | Medicine, Research & Experimental | 223 | 8% | 0% | 49 |
7 | Biophysics | 81 | 5% | 0% | 31 |
8 | Polymer Science | 77 | 6% | 0% | 32 |
9 | Materials Science, Multidisciplinary | 56 | 11% | 0% | 61 |
10 | Chemistry, Medicinal | 41 | 3% | 0% | 19 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | SHENZHEN GENE ANTIBODY THER Y | 1018978 | 7% | 49% | 38 |
2 | NANOSCI NANOENGN INITIAT NUSNNI | 531558 | 3% | 65% | 15 |
3 | NANOSCI NANOENGN INITIAT | 144899 | 1% | 67% | 4 |
4 | BIOTECH BIOMED | 124190 | 1% | 29% | 8 |
5 | ENGN NANOMED | 123951 | 3% | 13% | 18 |
6 | EDWARD M COPELAND III CHAIR BREAST CANC | 108676 | 0% | 100% | 2 |
7 | HUBEI ENGN NDDS | 108676 | 0% | 100% | 2 |
8 | NANOSCI NANOENGN INITIAT NUSNNI NANOCORE | 108676 | 0% | 100% | 2 |
9 | HENAN HEREDITARY DIS MOL TARGET DRUG TH | 72450 | 0% | 67% | 2 |
10 | ST PAULS PHARM | 72450 | 0% | 67% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF NANOMEDICINE | 11136 | 5% | 1% | 27 |
2 | MOLECULAR PHARMACEUTICS | 9295 | 4% | 1% | 24 |
3 | DRUG DELIVERY | 6697 | 2% | 1% | 13 |
4 | COLLOIDS AND SURFACES B-BIOINTERFACES | 6146 | 5% | 0% | 29 |
5 | BIOMATERIALS | 5960 | 7% | 0% | 41 |
6 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 5020 | 7% | 0% | 39 |
7 | EXPERT OPINION ON DRUG DELIVERY | 3054 | 1% | 1% | 8 |
8 | JOURNAL OF BIOMEDICAL NANOTECHNOLOGY | 2853 | 2% | 1% | 9 |
9 | JOURNAL OF CONTROLLED RELEASE | 2784 | 3% | 0% | 20 |
10 | NANOMEDICINE | 2562 | 1% | 1% | 8 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |